Treatment

FOSFOMYCIN , Placebo for MV140, PIVMECILLINAM , NITROFURANTOIN clinical trials

1 indexed studies · 0 currently recruiting

AuthorisedTherapeutic confirmatory (Phase III)
Multicentre, randomised, double-blind, placebo-controlled clinical trial to confirm the efficacy, safety, and clinical impact of the mucosal bacterial therapeutic vaccine MV140 in women with non-complicated recurrent urinary tract infections (rUTIs).
This study is testing a new 'bacterial vaccine' called MV140 for women who get frequent urinary tract infections (UTIs). It aims to see if MV140 can help prevent new UTIs and if it's safe to use, compared to a dummy treatment.
For: Recurrent Non-Complicated Urinary Tract Infections (rUTIs).
Portugal